Eye Care

The once-daily solution will be the first once-daily eye-itch allergy-relief drop to be available without a prescription in the United States.

Audible prescription labels will be available in-store at more than 420 Canadian pharmacy locations, including those at Lawtons Drugs, Sobeys, Safeway, Thrifty Foods, Foodland, IGA (western Canada), and FreshCo.

Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.

Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).

Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester/Manchester, discusses best practices for encouraging collaboration between pharmacy and optometry students.

Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester, discusses the links between ophthalmic conditions, over-the-counter ophthalmic products, and pharmacists.

Kaelen C. Dunican, PharmD, Professor at MCPHS University—Worcester/Manchester, MA discusses an interprofessional, educational activity with pharmacy and optometry students for reviewing common, self-treatable ophthalmic conditions.

JK is experiencing gastrointestinal effects. What could be the cause?

Did you know that eyedrops are color-coded for patient safety and adherence?

Vector-based gene therapy shows efficacy treating glaucoma.

Daily eye drops may increase medication nonadherence in patients with glaucoma.

Stem cell exosomes observed to protect retinal cells in a recent study.

Observing retinal changes and treating patients with an anti-diabetic drug could protect against Parkinson’s disease progression.

Patients who received their prescriptions by mail were the least likely to be adherent.

Seventeen states with medical marijuana laws saved Medicare Part D approximately $165.2 million in 2013.

Medicated ring shows better adherence rate and decreased eye pressure in patients with glaucoma or ocular hypertension.

Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.

Metformin use is associated with a reduced risk of glaucoma development among diabetics.

Glaucoma patients typically have ever-changing drug therapy regimens involving multiple eye drop products.

The FDA is reviewing a novel treatment for patients with open angle glaucoma or ocular hypertension.

Early detection and treatment are key to protecting eyesight.

Early detection and treatment are key to protecting eyesight.

This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.

Switching patients with glaucoma to generic medications can improve their adherence to ophthalmic drug therapies, according to researchers from the University of Michigan Kellogg Eye Center and College of Pharmacy.

Latanoprost eye drops may significantly reduce the risk of vision loss in patients with glaucoma.

Latanoprostene bunod (Vesneo) demonstrated noninferiority to timolol maleate (Timoptic 5%) in pivotal Phase 3 studies.

Selenium and vitamin E supplementation will not prevent cataracts in men, a new study suggests.